Biogen (BUE:BIIB) Net Interest Margin (Bank Only) %


BUE:BIIB Biogen Inc BUE:BIIB
62 GF Score
Price ARS25,180.00
GF Value ARS23,166.42
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Biogen Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

BUE:BIIB
62GF Score
Biogen Inc BUE:BIIB
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biogen (BUE:BIIB) Overvalued in 2026?

Based on GuruFocus' analysis, Biogen stock appears to be overvalued. The current stock price of ARS25,180.00 is trading 8.7% above its estimated GF Value™ of ARS23,166.42. GuruFocus considers Biogen to be Fairly Valued.

Key valuation signals for BUE:BIIB:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ARS23,166.42 vs. price of ARS25,180.00 (8.7% above fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the BUE:BIIB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biogen Business Description

Address 225 Binney Street, Cambridge, MA, USA, 02142
Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).
62GF Score

Get the complete analysis for BUE:BIIB

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS25,180.00
Price
ARS23,166.42
GF Value